Todd Lynch Joins BioAgilytix Labs As SVP And Chief Financial Officer

DURHAM, N.C.--(BUSINESS WIRE)--BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has welcomed Todd Lynch, CPA to its executive leadership team as SVP and Chief Financial Officer. With more than 23 years of experience in biotechnology, big pharma, clinical diagnostics, and contract research organizations ranging from pre-revenue to Fortune 500 companies, Mr. Lynch will play a key role in the development and execution of strategies to support BioAgilytix's rapid growth.

Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.